Related Experiment Video
Updated: May 28, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
204
FROM ONCOLOGIST TO SURGEON - GENETICS IN COLORECTAL METASTASIS FOR SURGEONS
Marília Polo Mingueti E Silva1,2,3, Jorge Sabbaga1,2,3, Henry Luiz Najman1
1D'Or Institute for Research and Education - São Paulo (SP), Brazil.
Summary
Colorectal cancer (CRC) risk factors include environmental and hereditary elements. Understanding sporadic, inherited, and familial CRC, including Lynch syndrome and polyposis, aids in diagnosis and treatment.
Area of Science:
- Oncology
- Gastroenterology
- Genetics
Background:
- Colorectal cancer (CRC) presents significant health challenges, with high incidence rates in Brazil.
- CRC risk factors are broadly categorized into environmental and hereditary, influencing disease presentation as sporadic, inherited, or familial.
- Sporadic CRC, common over age 50, lacks family history and is linked to diet and environment, accounting for ~70% of cases.
Purpose of the Study:
- To review the etiological factors of colorectal cancer (CRC).
- To differentiate between sporadic, inherited, and familial forms of CRC.
- To highlight the role of polyps and genetic syndromes in CRC development and management.
Main Methods:
- Literature review of colorectal cancer risk factors and classifications.
- Analysis of etiological pathways including environmental, hereditary, and genetic predispositions.
- Examination of specific genetic syndromes associated with CRC, such as Lynch syndrome and various polyposis conditions.
Main Results:
- Sporadic CRC, driven by environmental and dietary factors, constitutes the majority of cases (~70%).
- Hereditary factors account for less than 10% of CRC, often manifesting with colonic polyps.
- Identified hereditary conditions include Lynch syndrome (HNPCC), familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), and hamartomatous polyposis syndromes.
Conclusions:
- Effective CRC management requires understanding its diverse origins, from lifestyle to genetic predispositions.
- Genetic syndromes like Lynch syndrome and polyposis significantly elevate cancer risk.
- Advances in targeted therapies and biomarker analysis are crucial for treating metastatic CRC.
Related Concept Videos
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K

